The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase 2 study of olaparib and durvalumab in metastatic castrate-resistant prostate cancer (mCRPC) in an unselected population.
 
Fatima Karzai
No Relationships to Disclose
 
Ravi Amrit Madan
Speakers' Bureau - Boehringer Ingelheim (I); Janssen (I); Pfizer (I)
 
Helen Owens
No Relationships to Disclose
 
Anna Couvillon
No Relationships to Disclose
 
Amy Hankin
No Relationships to Disclose
 
Monique Williams
No Relationships to Disclose
 
Marijo Bilusic
Consulting or Advisory Role - Astellas Pharma; Bayer; Dendreon
Speakers' Bureau - Dendreon
Research Funding - Ambry Genetics (Inst); Bavarian Nordic (Inst); Johnson & Johnson (Inst); Sotio (Inst)
 
Lisa M. Cordes
No Relationships to Disclose
 
Jane B Trepel
No Relationships to Disclose
 
Keith Killian
No Relationships to Disclose
 
Paul S. Meltzer
No Relationships to Disclose
 
James L. Gulley
Research Funding - Astellas Medivation (Inst); Bavarian Nordic (Inst); Celgene (Inst); EMD Serono (Inst); Pfizer (Inst)
 
Jung-min Lee
No Relationships to Disclose
 
William L. Dahut
No Relationships to Disclose